| pubmed-article:18808343 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18808343 | lifeskim:mentions | umls-concept:C0000854 | lld:lifeskim |
| pubmed-article:18808343 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
| pubmed-article:18808343 | lifeskim:mentions | umls-concept:C0282386 | lld:lifeskim |
| pubmed-article:18808343 | lifeskim:mentions | umls-concept:C0949285 | lld:lifeskim |
| pubmed-article:18808343 | lifeskim:mentions | umls-concept:C0450442 | lld:lifeskim |
| pubmed-article:18808343 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:18808343 | pubmed:dateCreated | 2008-9-23 | lld:pubmed |
| pubmed-article:18808343 | pubmed:abstractText | Coadministration of oral divalent or trivalent cation-containing compounds with oral fluoroquinolones may impair fluoroquinolone absorption. Among 3,134 patients who received a course of oral levofloxacin, coadministration was significantly associated with subsequent identification of a levofloxacin-resistant isolate. Strategies to curb the emergence of fluoroquinolone resistance should include avoiding the coadministration of divalent or trivalent cation-containing compounds and fluoroquinolone. | lld:pubmed |
| pubmed-article:18808343 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18808343 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18808343 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18808343 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18808343 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18808343 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18808343 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18808343 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18808343 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18808343 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:18808343 | pubmed:issn | 1559-6834 | lld:pubmed |
| pubmed-article:18808343 | pubmed:author | pubmed-author:SynnestvedtMa... | lld:pubmed |
| pubmed-article:18808343 | pubmed:author | pubmed-author:LautenbachEbb... | lld:pubmed |
| pubmed-article:18808343 | pubmed:author | pubmed-author:WeinerMark... | lld:pubmed |
| pubmed-article:18808343 | pubmed:author | pubmed-author:CohenKeira... | lld:pubmed |
| pubmed-article:18808343 | pubmed:author | pubmed-author:GasinkLeanne... | lld:pubmed |
| pubmed-article:18808343 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18808343 | pubmed:volume | 29 | lld:pubmed |
| pubmed-article:18808343 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18808343 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18808343 | pubmed:pagination | 975-7 | lld:pubmed |
| pubmed-article:18808343 | pubmed:meshHeading | pubmed-meshheading:18808343... | lld:pubmed |
| pubmed-article:18808343 | pubmed:meshHeading | pubmed-meshheading:18808343... | lld:pubmed |
| pubmed-article:18808343 | pubmed:meshHeading | pubmed-meshheading:18808343... | lld:pubmed |
| pubmed-article:18808343 | pubmed:meshHeading | pubmed-meshheading:18808343... | lld:pubmed |
| pubmed-article:18808343 | pubmed:meshHeading | pubmed-meshheading:18808343... | lld:pubmed |
| pubmed-article:18808343 | pubmed:meshHeading | pubmed-meshheading:18808343... | lld:pubmed |
| pubmed-article:18808343 | pubmed:meshHeading | pubmed-meshheading:18808343... | lld:pubmed |
| pubmed-article:18808343 | pubmed:meshHeading | pubmed-meshheading:18808343... | lld:pubmed |
| pubmed-article:18808343 | pubmed:meshHeading | pubmed-meshheading:18808343... | lld:pubmed |
| pubmed-article:18808343 | pubmed:meshHeading | pubmed-meshheading:18808343... | lld:pubmed |
| pubmed-article:18808343 | pubmed:meshHeading | pubmed-meshheading:18808343... | lld:pubmed |
| pubmed-article:18808343 | pubmed:meshHeading | pubmed-meshheading:18808343... | lld:pubmed |
| pubmed-article:18808343 | pubmed:meshHeading | pubmed-meshheading:18808343... | lld:pubmed |
| pubmed-article:18808343 | pubmed:meshHeading | pubmed-meshheading:18808343... | lld:pubmed |
| pubmed-article:18808343 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18808343 | pubmed:articleTitle | Coadministration of oral levofloxacin with agents that impair absorption: impact on antibiotic resistance. | lld:pubmed |
| pubmed-article:18808343 | pubmed:affiliation | Divisions of Infectious Diseases, Departments of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA. | lld:pubmed |
| pubmed-article:18808343 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18808343 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:18808343 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
